Single-Cell Analysis Platform

BD (Becton, Dickinson and Company)


Introducing BD Rhapsody, a platform for single-cell analysis with the ability to detect rare molecules responsible for biological diversity that are often missed with whole-transcriptome profiling. Developed using unique molecular index (UMI) technology, BD Rhapsody is a complete system of reagents, instruments, and software for targeted gene-expression analysis of tens of thousands of individual cells. The product was previously in limited commercial release under the name Resolve. The company will offer both application-specific targeted panels and enable customers to design their own custom, targeted panels.

Previous articlePumpkin Genomes Sequenced in Time for Halloween, Revealing Curious Evolution
Next articleAstraZeneca Asthma Candidate Tralokinumab Fails Two Phase III Trials